Price $16.64 |
Market Cap
69.3M
|
Sector Health Care |
Div. Growth
-100.00%
|
|
P/E
-
|
P/B
5.06
|
P/S
170.03
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
20.8
|
Op. Cash Flow
3.1K
|
FCF
0.8
|
|
Op. Margin
-32.70%
|
Net Margin
-130.40%
|
ROE
-3.80%
|
ROI
-
|
|
ROA
-2.90%
|
EPS Growth
-376.80%
|
Current Ratio
-
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | $11.57 | - | - | 12.39B | Strong Buy |
| Champions Oncology Inc (CSBR) | $9.44 | - | - | 116.2M | Strong Buy |
| Advanz Pharma Corp Ltd (CXRXF) | $4.02 | - | - | 159M | Strong Buy |
| Community Health Systems Inc (CYH) | $4.51 | - | - | 589.7M | Strong Buy |
| International Stem Cell Corp (ISCO) | $0.68 | - | - | 6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
